NURIX THERAPEUTICS INC shareholders Q3 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 129 filers reported holding NURIX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIDUCIARY TRUST CO 14,074$110,6220.00%
DIMENSIONAL FUND ADVISORS LP 958,043$7,530,9980.00%
MARSHALL WACE, LLP 127,509$1,002,2220.00%
SG Americas Securities, LLC 20,639$1620.00%
Nuveen Asset Management, LLC 663,260$5,213,2230.00%
BlackRock Inc. 4,518,554$35,515,8340.00%
METROPOLITAN LIFE INSURANCE CO/NY 2,703$21,2460.00%
AMERICAN INTERNATIONAL GROUP, INC. 23,757$186,7300.00%
GOLDMAN SACHS GROUP INC 363,526$2,857,3140.00%
Mariner, LLC 31,927$250,9460.00%
MetLife Investment Management, LLC 23,288$183,0440.00%
Swiss National Bank 84,800$666,5280.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 568,576$4,469,0070.00%
TWO SIGMA INVESTMENTS, LP 26,757$210,3100.00%
UBS ASSET MANAGEMENT AMERICAS INC 240,608$1,891,1790.00%
VANGUARD GROUP INC 2,714,845$21,338,6820.00%
PANAGORA ASSET MANAGEMENT INC 18,171$142,8240.00%
Man Group plc 23,979$188,4750.00%
Arizona State Retirement System 10,980$86,3030.00%
RHUMBLINE ADVISERS 75,049$589,8740.00%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q3 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.